Further contract for Cleveland BioLabs

Cleveland BioLabs, who won a DoD contract earlier this year, was awarded a further contract from the US Department of Health and Human Services to work on their drug to counter the effects of radiation exposure. This contract is worth over $13 M and builds on the $9 M one from earlier this year.

For more see Buffalo Business First here.

Perseverance Pays

Cleveland Biolabs who at the beginning of the year failed to win a large contract from DoD for a drug to treat radiation poisoning was rewarded yesterday with another contract. See the article here. A previous post on the matter can be found here. This contract worth about $9 M pales compared to the one awarded previously at $225 M but will help the company move forward with its research. Read more